You are here

Amegakaryocytic Thrombocytopenia and Social Security Disability

The Social Security Administration receives millions of claims for Social Security Disability benefits each year. The increasing number of claims has resulted in a significant backlog of disability applications and appeals. While the average processing time for a disability claim varies from state to state, some applicants wait more than two years before being approved for Social Security Disability benefits.

The initial application process for disability benefits only takes about three to four months. Unfortunately, the majority of claims are denied at this stage of the application process and nearly 70 percent of applicants must go on to file an appeal in order to receive the disability benefits they are entitled to. This means even longer delays, as the appeal process can take more than a year to complete.

What happens to applicants who do not have months (or even years) to wait for Social Security Disability benefits? What about applicants with severe disabilities that warrant faster approval times? In these cases, the SSA's Compassionate Allowances program can help. Individuals who suffer from Amegakaryocytic Thrombocytopenia are just some of the patients who can benefit from the expedited approval process that the Compassionate Allowances program can offer.

If you have been diagnosed with Amegakaryocytic Thrombocytopenia, you will likely be approved for disability in a matter of weeks rather than a matter of months. The following information will help you understand the Amegakaryocytic Thrombocytopenia condition and how the condition qualifies you for benefits under the SSA's Compassionate Allowances program.

Amegakaryocytic Thrombocytopenia - Conditions and Symptoms

Amegakaryocytic Thrombocytopenia is a bone marrow disorder that results in a deficiency of platelets in the blood. These platelets are necessary in order for the blood to clot normally. When a deficiency occurs, the blood is unable to clot as it should.

The Amegakaryocytic Thrombocytopenia condition is thought to occur as a result of mutation in the C-MPL gene. Abnormalities in the central nervous system may also cause Amegakaryocytic Thrombocytopenia symptoms. Amegakaryocytic Thrombocytopenia can be present at birth or it may develop later on in life, although the condition is usually diagnosed by the time a patient reaches one month of age. An individual suffering from the condition will often experience a megakaryocyte deficiency, easy bruising, reduced blood platelets, impaired blood clotting and bleeding in the skin.

When an individual suffers from Amegakaryocytic Thrombocytopenia, the bone marrow fails produce the platelets or megakaryocytes necessary for proper blood clotting. If an individual who suffers from the condition begins to bleed, the blood does not clot. This may result in dangerous bleeding and the need for immediate medical attention. In some cases, the bone marrow will also stop producing red blood cells and neutrophils. Individuals who suffer from Amegakaryocytic Thrombocytopenia are at an increased risk of developing leukemia as well.

When diagnosing the Amegakaryocytic Thrombocytopenia condition, a doctor will order lab tests including genetic testing of the MPL gene, bone marrow aspirations and biopsies. Currently, the only successful known treatment for this condition is a bone marrow or stem cell transplant. In some cases, frequent platelet transfusions are necessary to help improve an individual's platelet levels.

Filing for Social Security Disability with Amegakaryocytic Thrombocytopenia

Individuals who suffer from Amegakaryocytic Thrombocytopenia often qualify for disability benefits under the SSA's Compassionate Allowances program. This means that an individual who is diagnosed with the condition may be approved for disability benefits in a matter of weeks, rather than having to wait months or even years before their disability benefits begin.

Although Amegakaryocytic Thrombocytopenia is a condition listed under the SSA's Compassionate Allowances listings, it is important to include as much medical documentation as possible when submitting your claim for disability benefits. Not all adjudicators are familiar with the condition and its severity, and it is important that you provide as much medical evidence as possible to help the individual who is processing your disability claim.

If your application for Social Security Disability benefits due to a diagnosis of Amegakaryocytic Thrombocytopenia is submitted properly, you could be approved for benefits in less than a month. It is important, however, that your application be presented properly in order to avoid a delay in the approval of your disability benefits.

Your Amegakaryocytic Thrombocytopenia Social Security Disability Case

Amegakaryocytic Thrombocytopenia is one of the 88 conditions listed under the Social Security Administration's Compassionate Allowances program. Because of this, your application for benefits is likely to be approved quickly and you may begin receiving disability benefits in a month or less. That does not mean, however, that you should not consult with a Social Security attorney or advocate when preparing your claim for Social Security Disability benefits.

If you want to have the best chance of a quick approval and a hassle-free disability claim, a disability advocate or attorney can help you present your application in the best light possible to the Social Security Administration. He or she will make sure that all of the necessary documentation is included with your application for disability benefits and that the adjudicator has the information necessary to understand your claim and how it qualifies under the Compassionate Allowances listings.

If you would like to learn more about the Social Security Compassionate Allowances program or if you would like to find out whether or not you qualify for Social Security Disability benefits due to your diagnosis of Amegakaryocytic Thrombocytopenia, click here for a free review of your Social Security Disability case.